Last updated: July 17, 2026

Application No. 19/461,192

MULTISPECIFIC BINDING PROTEINS THAT BIND DECTIN-1 AND TROP-2 AND METHODS OF USE THEREOF

Non-Final OA

Filed

Jan 27, 2026

Priority

Jul 31, 2023 — provisional 63/530,018 +1 more

Examiner

LU, CHENG

Art Unit

1642

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Dren Bio Management Inc.

OA Round

1 (Non-Final)

This examiner grants 54% of cases after interview

— +66.2% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 214 resolved cases, 2023–2026

Examiner Intelligence

LU, CHENG View full profile →

Grants 54% of resolved cases

Career Allowance Rate

115 granted / 214 resolved

-6.3% vs TC avg

Strong +66% interview lift

Without

With

+66.2%

Interview Lift

resolved cases with interview

Typical timeline

3y 3m

Avg Prosecution

51 currently pending

Career history

278

Total Applications

across all art units

Statute-Specific Performance

§101

1.6%

-38.4% vs TC avg

§103

28.3%

-11.7% vs TC avg

§102

4.6%

-35.4% vs TC avg

§112

21.9%

-18.1% vs TC avg

Black line = Tech Center average estimate • Based on career data from 214 resolved cases

Prosecution Timeline

Jan 27, 2026

Application Filed

Jun 05, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/271,500

Patent 12655462

PLK1 TARGET PHOSPHORYLATION STATUS AND TREATMENT OF CANCER WITH PLK1 INHIBITORS

5y 3m to grant Granted Jun 16, 2026

17/656,698

Patent 12624122

AFFINITY MATURATED TAG72 SPECIFIC SINGLE CHAING ANTIBODIES

4y 1m to grant Granted May 12, 2026

17/184,360

Patent 12606868

MOLECULAR BIOMARKERS AND TARGETS FOR FUCHES' ENDOTHELIAL CORNEAL DYSTROPHY AND GLAUCOMA

5y 1m to grant Granted Apr 21, 2026

18/600,481

Patent 12583939

BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND HER2, AND METHODS OF USE THEREOF

2y 0m to grant Granted Mar 24, 2026

18/758,038

Patent 12570765

Trispecific T cell Engagers

1y 8m to grant Granted Mar 10, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

54%

Grant Probability

99%

With Interview (+66.2%)

3y 3m (~2y 9m remaining)

Median Time to Grant

Low

PTA Risk

Based on 214 resolved cases by this examiner. Grant probability derived from career allowance rate.